Skip to content

Comparison of QLB and TFP Block for Postoperative Analgesia in Laparoscopic Inguinal Hernia

Comparison of the Effects of Ultrasound-Guided Lateral Quadratus Lumborum Block and Transversalis Fascia Plane Block on Postoperative Analgesia in Patients Undergoing Laparoscopic Inguinal Hernia Repair: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07604259
Enrollment
90
Registered
2026-05-22
Start date
2026-06-10
Completion date
2027-05-10
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

İnguinal Hernia, Post Operative Pain

Keywords

Laparoscopic inguinal hernia, Quadratus Lumborum Block, Transversalis Fascia Plane Block, Postoperative analgesia, Regional anesthesia.

Brief summary

This randomized controlled trial aims to compare the effects of ultrasound-guided lateral Quadratus Lumborum Block (QLB) and Transversalis Fascia Plane (TFP) block on postoperative analgesia in patients undergoing laparoscopic inguinal hernia repair. Ninety patients will be randomly assigned to one of three groups: Group QLB, Group TFP, or Group Control. The primary objective is to compare postoperative pain scores (NRS) at various time points within the first 24 hours. Secondary objectives include evaluating the need for rescue analgesia, total tramadol consumption, and the incidence of opioid-related side effects.

Detailed description

Laparoscopic inguinal hernia repair is a standard, minimally invasive procedure. However, moderate pain is common in the first 24 hours postoperatively, originating from somatic pain at trocar sites and visceral pain from peritoneal irritation and mesh placement. Multimodal analgesia, including fascial plane blocks, is recommended to reduce opioid consumption and improve pain control. In this prospective, randomized, controlled, single-center trial, 90 patients (ASA I-III, aged 18-65) scheduled for elective laparoscopic inguinal hernia repair under general anesthesia will be allocated into three parallel arms (n=30 each) via computer-based randomization. Group QLB: Will receive bilateral ultrasound-guided lateral Quadratus Lumborum Block (total 40 mL 0.25% bupivacaine) prior to extubation, along with 10 mL 0.25% bupivacaine infiltration at port sites. Group TFP: Will receive bilateral ultrasound-guided Transversalis Fascia Plane Block (total 40 mL 0.25% bupivacaine) prior to extubation, along with 10 mL 0.25% bupivacaine infiltration at port sites. Group Control: Will receive only port site infiltration (total 20 mL 0.25% bupivacaine). All procedures will be performed aseptically by the same surgical and anesthesia team. Postoperatively, all patients will receive 1 g intravenous paracetamol every 8 hours. Postoperative pain will be assessed using the Numeric Rating Scale (NRS) by an anesthesiologist blinded to the group allocation. Intravenous tramadol (100 mg) will be administered as rescue analgesia if the NRS score is ≥ 4. Total 24-hour tramadol consumption, along with block-related complications and opioid-related side effects (nausea, vomiting, sedation), will be recorded.

Interventions

Bilateral ultrasound-guided lateral QLB with 20 mL of 0.25% bupivacaine per side (total 40 mL). Plus, 10 mL of 0.25% bupivacaine infiltration at trocar insertion sites.

Bilateral ultrasound-guided TFP block with 20 mL of 0.25% bupivacaine per side (total 40 mL). Plus, 10 mL of 0.25% bupivacaine infiltration at trocar insertion sites.

Local infiltration of 20 mL of 0.25% bupivacaine at the trocar insertion sites.

Sponsors

Medipol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled for elective laparoscopic inguinal hernia repair. * American Society of Anesthesiologists (ASA) physical status I, II, or III. * Age between 18 and 65 years. * Provided written informed consent.

Exclusion criteria

* History of allergy to local anesthetics. * Presence of coagulopathy. * Signs of infection at the intended block application site. * Body Mass Index (BMI) ≥ 35 kg/m². * History of chronic opioid use. * Presence of neurological disease. * Refusal to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Numeric Rating Scale (NRS) Pain ScoreAt 0, 3, 6, 12, 18, and 24 hours postoperatively.Postoperative pain intensity assessed using the Numeric Rating Scale (NRS). The scale ranges from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain". Higher scores represent worse pain outcomes.

Secondary

MeasureTime frameDescription
Total Tramadol ConsumptionDuring the first 24 hours postoperatively.The cumulative dose of intravenous tramadol (in milligrams) administered as rescue analgesia.
Need for Rescue AnalgesiaDuring the first 24 hours postoperativelyThe number of patients requiring rescue analgesia (tramadol 100 mg IV) when the NRS score is ≥ 4.
Incidence of Opioid-Related Side EffectsDuring the first 24 hours postoperatively.The number of patients experiencing postoperative nausea, vomiting, or sedation.
Incidence of Block-Related ComplicationsDuring the first 24 hours postoperatively.The number of patients experiencing complications related to the regional block application, such as hematoma, infection, or local anesthetic systemic toxicity (LAST).

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026